Healthcare provider profile · identity verified

Matthew J. Markey, M.D.

Internal Medicine · CUMMING, GA · NPI 1740278753

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	538	137
Levothyroxine Sodium	Levothyroxine Sodium	375	98
Amlodipine Besylate	Amlodipine Besylate	274	81
Methylprednisolone	Methylprednisolone	273	167
Pantoprazole Sodium	Pantoprazole Sodium	240	69
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	232	145
Lisinopril	Lisinopril	195	56
Rosuvastatin Calcium	Rosuvastatin Calcium	192	53
Tamsulosin Hcl	Tamsulosin Hcl	191	53
Metformin Hcl	Metformin Hcl	185	50
Diclofenac Sodium	Diclofenac Sodium	180	72
Metoprolol Succinate	Metoprolol Succinate	161	37
Hydrochlorothiazide	Hydrochlorothiazide	159	39
Simvastatin	Simvastatin	150	40
Eliquis	Apixaban	146	33
Gabapentin	Gabapentin	133	33
Omeprazole	Omeprazole	128	35
Glipizide	Glipizide	125	31
Clonazepam	Clonazepam	121	19
Losartan Potassium	Losartan Potassium	119	35
Alprazolam	Alprazolam	112	16
Allopurinol	Allopurinol	106	33
Trazodone Hcl	Trazodone Hcl	100	27
Furosemide	Furosemide	98	26
Sertraline Hcl	Sertraline Hcl	96	21
Albuterol Sulfate Hfa	Albuterol Sulfate	90	25
Metoprolol Tartrate	Metoprolol Tartrate	87	30
Carvedilol	Carvedilol	78	22
Montelukast Sodium	Montelukast Sodium	78	23
Bupropion Xl	Bupropion Hcl	77	24
Tramadol Hcl	Tramadol Hcl	75	16
Zolpidem Tartrate	Zolpidem Tartrate	72	19
Potassium Chloride	Potassium Chloride	69	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	19
Levofloxacin	Levofloxacin	58	41
Meloxicam	Meloxicam	56	15
Lorazepam	Lorazepam	52	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	52	40
Clopidogrel	Clopidogrel Bisulfate	51	14
Fluticasone Propionate	Fluticasone Propionate	48	16
Azithromycin	Azithromycin	47	35
Hydralazine Hcl	Hydralazine Hcl	47	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	47	suppressed
Paroxetine Hcl	Paroxetine Hcl	45	13
Finasteride	Finasteride	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	12
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Fenofibrate	Fenofibrate	40	11
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Spironolactone	Spironolactone	39	suppressed
Alendronate Sodium	Alendronate Sodium	38	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	18
Escitalopram Oxalate	Escitalopram Oxalate	35	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Prednisone	Prednisone	32	13
Benazepril Hcl	Benazepril Hcl	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	13
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Atenolol	Atenolol	27	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Fluconazole	Fluconazole	27	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	15
Clonidine Hcl	Clonidine Hcl	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	15
Cephalexin	Cephalexin	24	18
Myrbetriq	Mirabegron	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Dutasteride	Dutasteride	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Famotidine	Famotidine	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Ozempic	Semaglutide	22	suppressed
Telmisartan	Telmisartan	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Humulin N	Insulin Nph Human Isophane	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Colchicine	Colchicine	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Nystatin	Nystatin	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Clotrimazole	Clotrimazole	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Warfarin Sodium	Warfarin Sodium	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Sulfacetamide Sodium	Sulfacetamide Sodium	13	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Dofetilide	Dofetilide	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error